Search
Returning search results with filters:
Remove filter for
Audience: Health professionals
Remove filter for
Last updated: June 2021
Remove filter for
Last updated: 2021
Remove filter for
Type: Alert
Clear all
Please note: using the search filters may not provide accurate search results for records prior to November 2021. When searching for older records, please ensure that you use the include archived checkbox.
Displaying 1 - 7 of 7 items.
CHAMPIX (varenicline) — Potential Risk Posed by Long-Term Exposure to Nitrosamine Impurity, N-nitrosovarenicline, Exceeding Acceptable Intake Limit
Starting date:
June 30,…
AlertHealth professional risk communication | 2021-06-30
AstraZeneca COVID-19 Vaccine and COVISHIELD: Risk of Capillary Leak Syndrome
Starting date:
June 29, 2021
Posting date:
June 29, 2021
Type of communication:
Dear Healthcare…
AlertHealth professional risk communication | 2021-06-29
Health Canada issues label change on the AstraZeneca and COVISHIELD COVID-19 vaccines
Starting date:
April 14, 2021
Posting date:
June 29, 2021
Type of communication:
Advisory…
AlertPublic advisory | 2021-06-29
Medtronic Heartware Ventricular Assist Device System - Recall Due to Risk of Neurological Adverse Events, Mortality and Delay or Failure to Restart
Starting date:
June 24,…
AlertHealth professional risk communication | 2021-06-25
One lot of Linessa 21 birth control pills recalled due to missing and mispackaged pills
Starting date:
June 19, 2021
Type of communication:
Advisory
Subcategory:
Drugs
Source…
AlertPublic advisory | 2021-06-19
UPDATED INFORMATION – October 29, 2021
Further to the Health Canada communications below issued on June 14, 2021 (and updated on June 24, 2021, and August 3, 2021), Health Canada has authorized a 2-month shelf life extension (from 7 months to 9 months…
AlertHealth professional risk communication | 2021-06-14
Labelling update regarding the use of non-steroidal anti-inflammatory drugs (NSAIDs) beyond 20 weeks of pregnancy and risk of kidney damage to unborn babies
Labelling update regarding the use of non-steroidal anti-inflammatory drugs (NSAIDs) beyond 20 weeks of pregnancy and risk of kidney damage to unborn babies
Starting date:…
AlertPublic advisory | 2021-06-08